Skip to main content
Premium Trial:

Request an Annual Quote

DuPont Licenses DxS Multiplex Assay Technology

NEW YORK (GenomeWeb News) — DuPont's Qualicon business has licensed DxS' Scorpion multiplex assay platform for use in developing diagnostic tests for the food industry.

Under the agreement, DuPont Qualicon will use the Scorpions technology, a closed-tube platform for PCR analysis for which Manchester, UK-based DxS owns the worldwide intellectual property rights, for use in its development of rapid multiplex assays for detecting microorganisms in food as well as beverage safety and quality.

Financial terms of the agreement were not released.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.